Diabetic Neuropathies

They are associated with diabetes mellitus and are generally described as diabetic peripheral nerve dysfunction when other causes are excluded. The supplied literature identifies hyperglycemia, disorders of lipid metabolism, and abnormalities in insulin signaling pathways as initiating factors in pathogenesis. The grounding does not support a more specific causal hierarchy beyond these diabetes-related mechanisms.

The core mechanism described is diabetic microvascular injury to the vasa nervorum, leading to nerve ischemia and dysfunction. The literature also points to broader structural alterations in diabetic peripheral neuropathy and to complex, incompletely elucidated mechanisms in painful diabetic neuropathy. Shared mechanisms discussed include neurovascular and neuroimmune interactions, axonopathy, demyelination, and impaired balance between neural plasticity and neurodegeneration.

Longer duration of diabetes is associated with higher prevalence of diabetic peripheral neuropathy. The supplied abstracts also indicate that diabetic neuropathy is common in type 2 diabetes and that prevalence increases over time, but they do not provide additional independent risk factors. The grounding does not support other specific risk factors.

Management is described at the level of diagnostic classification, severity estimation, and treatment of diabetic peripheral neuropathies, autonomic neuropathy, and painful diabetic neuropathy. For painful diabetic neuropathy, the literature emphasizes mechanism-based and phenotype-based approaches to individualized pain management. The grounding supports treatment as a general category of neuropathic pain management, but does not specify particular drug classes or modalities in detail.